Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
EJIFCC
|
October 16, 2025
TPMT Genotyping in 1000 Indian Patients: 14-Year Experience from a Tertiary-Care Hospital
Minal Umesh Paradkar, Swarup Arvind Vaishali Shah, Rani Deepak, et al.
JCI Insight
|
January 12, 2018
Retinal de novo lipogenesis coordinates neurotrophic signaling to maintain vision
Rithwick Rajagopal, Sheng Zhang, Xiaochao Wei, et al.
ACS Omega
|
April 3, 2023
Electron-Phonon Interaction Contribution to the Total Energy of Group IV Semiconductor Polymorphs: Evaluation and Implications
Arjun Varma Ramasimha Varma, Shilpa Paul, Anup Itale, et al.
PDA Journal of Pharmaceutical Science and Technology
|
November 15, 2022
Multisite Qualification of an Automated Incubator and Colony Counter for Environmental and Bioburden Applications in Pharmaceutical Microbiology
Hans Joachim Anders, Daniel Männle, William Carpenter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 12, 2022
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
Eric Morand, Marilyn Pike, Joan T Merrill, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons
|
January 20, 2025
Predicting Robotic Hysterectomy Incision Time: Optimizing Surgical Scheduling with Machine Learning
Vaishali Shah, Halley C Yung, Jie Yang, et al.
Expert Opinion on Investigational Drugs
|
May 29, 2024
Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus
Eric F Morand, Marilyn Pike, J Merrill, et al.
Advances in Therapy
|
September 8, 2025
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus
Cristina Arriens, Eric F Morand, Anca D Askanase, et al.
Critical Ultrasound Journal
|
November 5, 2016
Pediatric emergency medicine point-of-care ultrasound: summary of the evidence
Jennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Critical Ultrasound Journal
|
February 5, 2017
Erratum to: Pediatric emergency medicine point-of-care ultrasound: summary of the evidence
Jennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
EJIFCC
|
October 16, 2025
TPMT Genotyping in 1000 Indian Patients: 14-Year Experience from a Tertiary-Care Hospital
Minal Umesh Paradkar, Swarup Arvind Vaishali Shah, Rani Deepak, et al.
JCI Insight
|
January 12, 2018
Retinal de novo lipogenesis coordinates neurotrophic signaling to maintain vision
Rithwick Rajagopal, Sheng Zhang, Xiaochao Wei, et al.
ACS Omega
|
April 3, 2023
Electron-Phonon Interaction Contribution to the Total Energy of Group IV Semiconductor Polymorphs: Evaluation and Implications
Arjun Varma Ramasimha Varma, Shilpa Paul, Anup Itale, et al.
PDA Journal of Pharmaceutical Science and Technology
|
November 15, 2022
Multisite Qualification of an Automated Incubator and Colony Counter for Environmental and Bioburden Applications in Pharmaceutical Microbiology
Hans Joachim Anders, Daniel Männle, William Carpenter, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 12, 2022
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
Eric Morand, Marilyn Pike, Joan T Merrill, et al.
JSLS : Journal of the Society of Laparoendoscopic Surgeons
|
January 20, 2025
Predicting Robotic Hysterectomy Incision Time: Optimizing Surgical Scheduling with Machine Learning
Vaishali Shah, Halley C Yung, Jie Yang, et al.
Expert Opinion on Investigational Drugs
|
May 29, 2024
Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus
Eric F Morand, Marilyn Pike, J Merrill, et al.
Advances in Therapy
|
September 8, 2025
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus
Cristina Arriens, Eric F Morand, Anca D Askanase, et al.
Critical Ultrasound Journal
|
November 5, 2016
Pediatric emergency medicine point-of-care ultrasound: summary of the evidence
Jennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Critical Ultrasound Journal
|
February 5, 2017
Erratum to: Pediatric emergency medicine point-of-care ultrasound: summary of the evidence
Jennifer R Marin, Alyssa M Abo, Alexander C Arroyo, et al.
Page
of 2